Fulgent Genetics (NASDAQ:FLGT) Azioni

Fulgent Genetics

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Fulgent Genetics Inc

On Monday, the U.S. and China agreed to a temporary reduction in most tariffs on each other&#8217;s goods, marking a considerable easing of trade tensions. As a result, major tech stocks caught in the trade war, such as Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Amazon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), climbed more than 4% during the pre-market trading session.
What Happened: The world&#8217;s two largest economies have agreed to a 90-day suspension of &#8220;reciprocal&#8221; tariffs, reducing them from 125% to 10%.&nbsp;However, the U.S. will maintain its 20% tariffs on Chinese imports linked to fentanyl, keeping the overall tariff level on China at 30%, <a href="https://www.cnbc.com/2025/05/12/us-and-china-agree-to-slash-tariffs-for-90-days.html">reported </a>CNBC.
As per the joint statement, Beijing has also agreed to suspend or lift all non-tariff countermeasures imposed since April 2, including sanctions on certain U.S. companies and export restrictions on key minerals, <a href="https://www.scmp.com/economy/global-economy/article/3309975/china-us-reduce-majority-tariffs-after-first-round-trade-talks?module=top_story&amp;pgtype=homepage">as per</a> the South China Morning Post.
This development comes after intensive trade talks between U.S. and Chinese representatives in Switzerland, with U.S. Treasury Secretary Scott Bessent expressing satisfaction with the discussions, stating, &#8220;We had very productive talks&nbsp;and I believe that the&nbsp;venue, here in Lake Geneva,&nbsp;added great equanimity to what&nbsp;was a very positive process.&#8221;
"Neither side wants a decoupling,&#8221; emphasized Bessent. 
Both countries have signaled their commitment to ongoing dialogue on economic and trade policy. Earlier in the day, the official handle of the Chinese Embassy in the U.S. stated, &#8220;high-level meeting on economic and trade affairs were in-depth, candid and constructive,&#8221; citing Chinese Vice Premier He Lifeng.
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/25/05/45314762/charlie-munger-was-once-asked-why-warren-buffett-was-so-much-richer-and-replied-he-got-an-earlier-start-before-adding-why-was-albert-einstein-poorer-than-i-was" target="_blank" rel="noreferrer noopener">Charlie Munger Was Once Asked Why Warren Buffett Was So Much Richer — He Replied, &#8216;He Got An Earlier Start,&#8217; Then Added, &#8216;Why Was Albert Einstein Poorer Than I Was?&#8217; &#8211; Benzinga</a>
Why It Matters: The weekend talks in Geneva, Switzerland, marked the first formal negotiations between the two superpowers since U.S. President Donald Trump imposed new tariffs of 145% on China earlier this year. Trump had stated that he "might speak with Chinese President Xi Jinping" based on the outcome in Switzerland.
This agreement comes in the wake of renewed<a href="https://www.benzinga.com/news/global/25/05/45337811/trump-announces-total-reset-as-us-china-trade-talks-aim-to-end-tariff-war"> trade negotiations </a>between the two nations, as reported. The talks, described by U.S. officials and President Trump as a potential &#8220;reset,&#8221; aimed to reduce tariffs and reestablish more stable trade terms. 
Despite the diplomatic tone, deep-rooted differences remain, particularly around technology, subsidies, and market transparency. The outcome of these talks is critical not just for U.S.–China relations, but for global trade stability in the months ahead. 
Investors were encouraged by the news of the tariff relief. During the pre-market trading session, shares of Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) climbed above 4%, while Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and Amazon Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) rose more than 6%. Meanwhile, Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) rose 3.5%.
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/25/05/45339953/apple-exec-says-iphone-users-are-ditching-google-search-now-chamath-palihaptiya-urges-the-tech-giant-to-stop-wait" target="_blank" rel="noreferrer noopener">Apple Executive Says iPhone Users Are Ditching Google — Now Chamath Palihaptiya Urges The Search Giant To Stop Waiting For Data And Start Fighting Models Like ChatGPT</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

News

Economics

Markets

General

AAPL

AMZN

NVDA

TSLA

Apple, Amazon, Nvidia Rise In Monday Premarket As US, China Agree To 90-Day Tariff Truce: 'Neither Side Wants A Decoupling'

The CNN Money Fear and Greed index showed almost no change in the overall market sentiment, while the index remained in the &#8220;Greed&#8221; zone on Friday.
U.S. stocks settled lower on Friday, with the Dow Jones index falling more than 100 during the session ahead of trade talks between the US and Chinese officials.
Major indices on the US also closed lower last week, with the S&amp;P 500 falling about 0.5% and the Nasdaq down around 0.3%. The Dow also declined almost 0.2% in the week.
Lyft, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) reported better-than-expected earnings for the first quarter and announced a $750 million share buyback plan on Thursday. EchoStar Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATS#NASDAQ">SATS</a>) reported wider-than-expected loss for the first quarter on Friday.
On the economic data front, U.S. initial jobless claims declined by 13,000 to 228,000 in the week ending May 3, compared to market estimates of 230,000. U.S. labor productivity in the nonfarm business sector declined by 0.8% during the first quarter compared to estimates of a 0.7% drop.
Most sectors on the S&amp;P 500 closed on a positive note, with real estate, consumer discretionary and energy stocks recording biggest gains on Friday. However, health care and communication services stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed lower by around 119 points to 41,249.38 on Friday. The S&amp;P 500 fell 0.07% to 5,659.91, while the Nasdaq Composite gained 0.01% at 17,928.92 during Friday's session.
Investors are awaiting earnings results from DaVita Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>), Fox Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOX#NASDAQ">FOX</a>) and NRG Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>) today.
At a current reading of 61.6, the index was in the &#8220;Greed&#8221; zone on Friday, versus a prior reading of 61.5.
What is CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based
&nbsp;on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45315727/top-3-industrials-stocks-that-may-collapse-in-may">Top 3 Industrials Stocks That May Collapse In May</a> </li>
</ul>
Photo via Shutterstock

Earnings

Pre-Market Outlook

Trading Ideas

LYFT

SATS

Dow Falls Over 100 Points, Also Records Weekly Loss: Fear & Greed Index Remains In 'Greed' Zone

Prominent investor Ross Gerber recently shared that, in his view, Alphabet Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) subsidiary Google-backed Waymo self-driving technology performs better than human drivers, hinting at growing pressure on ride-sharing and autonomous vehicle rivals.
What Happened: The CEO and co-founder of Gerber Kawasaki Wealth and Investment Management shared his experience on his X account after observing a Waymo vehicle navigate through congested beach traffic. 
&#8220;A Waymo navigated by us with precision that was better than a human. Waymos drive extremely well,&#8221; Gerber stated, adding that this development &#8220;is going to be very tough competition&#8221; for Uber Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) and Elon Musk&#8216;s Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>).
Gerber&#8217;s comments came in response to CBS Sunday Morning correspondent David Pogue&#8216;s segment highlighting Waymo&#8217;s achievement of 50 million miles driven without a fatality. According to Pogue&#8217;s report, Waymo plans expansion to 15 cities by year-end, offering rides at the &#8220;same price as Uber.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Yesterday in just packed beach traffic and horrid tourist drivers. A Waymo navigated by us with precision that was better than a human. Waymos drive extremely well. This is going to be very tough competition for uber and tesla. <a href="https://twitter.com/search?q=%24uber&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$uber</a> <a href="https://twitter.com/search?q=%24tsla&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$tsla</a> <a href="https://twitter.com/search?q=%24goog&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$goog</a> <a href="https://t.co/0VrfRYfYLM">https://t.co/0VrfRYfYLM</a>
&mdash; Ross Gerber (@GerberKawasaki) <a href="https://twitter.com/GerberKawasaki/status/1921629990283530368?ref_src=twsrc%5Etfw">May 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/25/05/45340216/openais-ipo-ambitions-hang-in-the-balance-as-microsoft-negotiates-equity-report">OpenAI&#8217;s IPO Ambitions Hang In The Balance As Microsoft Negotiates Equity: Report</a>
Why It Matters: The assessment from Gerber directly contradicts the position of prominent Tesla bull and Wedbush Securities analyst Dan Ives, who recently dismissed the Waymo and Toyota Motor Corp&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TM#NYSE">TM</a>) partnership as a <a href="https://www.benzinga.com/25/05/45126638/tesla-will-own-the-autonomous-market-dan-ives-says-shrugging-off-waymo-toyota-agreement">threat to Tesla&#8217;s autonomous ambitions</a>. &#8220;Tesla will own the autonomous market in my view and no one can compete with their scale and scope,&#8221; Ives posted, emphasizing Tesla&#8217;s upcoming Austin robotaxi launch in June as a &#8220;key chapter of growth.&#8221;
Waymo has established significant momentum in the autonomous vehicle race, recently announcing <a href="https://www.benzinga.com/25/04/45001569/waymo-announces-250000-weekly-paid-rides-across-four-us-cities-sundar-pichai-says-personal-ownership-an-option-in-the-future">it provides over 250,000</a> fully autonomous paid rides weekly across four major cities. 
The Alphabet subsidiary has formed a strategic partnership with Toyota to develop autonomous technology for personally owned vehicles, combining Waymo&#8217;s driving system expertise with Toyota&#8217;s manufacturing capabilities.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45339797/gary-black-doubles-down-on-ubers-autonomy-upside-reflects-on-tesla-debates-i-was-right-on-volume-pr-and-robotaxis">Gary Black Doubles Down On Uber&#8217;s Autonomy Upside, Reflects Debates With Tesla Faithful: &#8216;I Was Right&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image Via Shutterstock

Opinion

Tech

GOOG

GOOGL

UBER

Ross Gerber Calls Google-Backed Waymo's Self-Driving Taxis 'Better Than A Human,' Says They're 'Tough Competition' For Uber And Tesla

Economists have been predicting that retailers in the U.S. are likely to face pressure in the case of higher tariffs on China, as it is likely to &#8220;empty shelves&#8221; with a falling inventory-to-sales ratio.
What Happened: According to Torsten Slok, the chief economist at Apollo Academy, the inventory-to-sales ratio for retailers has fallen below the pre-pandemic level, sparking concerns about lower inventory as compared to the sales made by these retailers.
&#8220;The inventory-to-sales ratio for retailers was 1.5 before the pandemic, and now it is 1.3, see chart below,&#8221; the Apollo note stated.
Slok explained, &#8220;In other words, retailers will more quickly have empty shelves when goods no longer come in from China.&#8221;
This sentiment was also echoed by senior economist Mohamed El Erian in an X post. According to him, the ongoing high-level talks between China and the U.S. in Geneva, Switzerland, are likely to provide clarity on many concerns.
He highlights China&#8217;s &#8220;appetite for pain&#8221; and America&#8217;s fear of &#8220;empty shelves&#8221; as the primary matters that need to be solved via the ongoing talks.
&#8220;The outcome of this weekend's China-US tariff talks in Switzerland will be assessed in terms of what it reveals about China's appetite for pain, America's fear of &#8217;empty shelves,&#8217; and the way each country prioritizes the long-term objectives of trade policy. It will also be significant for many other countries, where there is already concern about the diversion of Chinese exports to their markets,&#8221; he said.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">An interesting week ahead for the global economy and markets, including on account of China-US tariff talks, the follow-up to the Federal Reserve policy meeting, and data: The outcome of this weekend's China-US tariff talks in Switzerland will be assessed in terms of what it…
&mdash; Mohamed A. El-Erian (@elerianm) <a href="https://twitter.com/elerianm/status/1921319822274523284?ref_src=twsrc%5Etfw">May 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/government/regulations/25/05/45340465/bill-ackman-slams-subsidies-for-contributing-to-37-trillion-national-debt-hails-trumps-drug-price-order">Bill Ackman Slams Subsidies For Contributing To $37 Trillion National Debt, Hails Trump&#8217;s Drug Price Order</a>
Why It Matters: Over the weekend, the White House and Chinese officials signaled significant <a href="https://www.benzinga.com/news/global/25/05/45337811/trump-announces-total-reset-as-us-china-trade-talks-aim-to-end-tariff-war">headway in trade negotiations</a> held in Geneva.
Treasury Secretary Scott Bessent lauded the &#8220;substantial progress,&#8221; while Trade Ambassador Jamieson Greer highlighted the swift agreement, expressing optimism that the deal would address the U.S.&#8217;s $1.2 trillion trade deficit, a &#8220;national emergency.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">BREAKING: U.S. Announces China Trade Deal in Geneva <a href="https://t.co/JjgvYAvAGe">pic.twitter.com/JjgvYAvAGe</a>
&mdash; The White House (@WhiteHouse) <a href="https://twitter.com/WhiteHouse/status/1921623939060519353?ref_src=twsrc%5Etfw">May 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
China&#8217;s Vice Commerce Minister Li Chenggang also announced an &#8220;important consensus,&#8221; predicting &#8220;good news for the world,&#8221; according to Reuters. Both sides indicated that details of this progress would be released on Monday.
Price Action: The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, fell on Friday. The SPY was down 0.13% to $564.34, while the QQQ declined 0.066% to $487.97, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
On Monday, the futures of S&amp;P 500, Dow Jones and Nasdaq 100 were trading higher ahead of the pre-open.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/government/regulations/25/05/45311562/mohamed-el-erian-flags-adverse-implications-for-domestic-industries-as-chinas-exports-rise-8-despite-21-drop-in-us-shipments" target="_blank" rel="noreferrer noopener">Mohamed El-Erian Flags ‘Adverse Implications' For Domestic Industries As China's Exports Rise 8% Despite 21% Drop In US Shipments</a></li>
</ul>
Photo: Orlowski Designs LLC/Shutterstock

Analyst Color

Government

Macro Economic Events

Market Summary

Regulations

Broad U.S. Equity ETFs

Futures

Analyst Ratings

ETFs

Economists Warn Of 'Empty Shelves' If Goods Stop Coming From China Amid Falling Inventory-To-Sales Ratio And Potential Tariffs

ACHC

ACHR

ACNT

AGEN

AIRJ

ALLT

ALTI

AMBC

AMPY

APEI

AQST

ARCT

ARWR

ASRT

ASYS

AUPH

BATRA

BATRK

Mobile Infrastructure Corporation Common Stock

BEEP

BETR

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BLDE

BLNK

CATX

CEPU

CHGG

CHRS

CLLS

CLPR

CMCL

CMPO

CNNE

CNTY

CPSS

CTMX

CTRI

CWCO

DOLE

EDIT

EXOD

FGEN

FOXA

FRPH

FTEK

FTRE

GAIA

GETY

GPRO

GRDN

HBIO

HFFG

HNRG

IHRT

IMNN

INDI

ISPR

KBDC

KPTI

KSPI

LAND

LEGH

LINC

LSEA

LTBR

METC

Ramaco Resources, Inc. - Class B Common Stock

METCB

MFIC

MLNK

MLYS

MNDY

MODG

MRVI

MVIS

MVST

NMRA

NOTE

NPWR

NRGV

NRXS

Earnings Scheduled For May 12, 2025

On Sunday, President Donald Trump announced on Truth Social that he plans to sign what he called the &#8220;<a href="https://www.benzinga.com/general/health-care/25/05/45339399/trump-says-prescription-drug-prices-set-to-drop-by-30-to-80-almost-immediately-thanks-to-most-favored-nation-plan-mark-cuban-urges-president-to-force-tran">most consequential executive order</a>&#8221; in U.S. history, aimed at lowering prescription drug prices.
What Happened: Trump said the executive order, set to be signed at 9 a.m. Monday, will implement a &#8220;Most Favored Nations&#8221; policy requiring pharmaceutical companies to charge U.S. consumers no more than the lowest price they offer for the same drug in any other country.
See More: <a href="https://www.benzinga.com/25/05/45338985/trump-reportedly-set-to-accept-flying-palace-from-qatar-white-house-says-lavish-gift-of-boeing-jumbo-jet-complies-with-all-applicable-laws">Trump Reportedly Set To Accept &#8216;Flying Palace&#8217; From Qatar, White House Says Lavish Gift Of Boeing Jumbo Jet Complies With &#8216;All Applicable Laws&#8217;</a>
Accusing pharmaceutical companies of overcharging American consumers, sometimes &#8220;five to ten times more&#8221; than patients in other countries, Trump slammed political opponents for enabling the status quo all these years.
Trump says that prescription drug prices will be reduced by &#8220;30% to 80%,&#8221; while rising throughout the world, to equalize and &#8220;bring fairness to America.&#8221;
Why It Matters: This move is expected to have the biggest impact on Medicare Part B drugs, which mainly constitute outpatient prescriptions and biologicals, the prices for which are directly managed by the Centers for Medicare &amp; Medicaid Services (CMS).
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th class="has-text-align-center" data-align="center">Drug Name</th>
<th class="has-text-align-center" data-align="center">Manufacturer(s)</th>
<th class="has-text-align-center" data-align="center">Total Spending</th>
<th class="has-text-align-center" data-align="center">Primary Use</th>
</tr>
</thead>
<tbody>
<tr>
<td class="has-text-align-center" data-align="center">Keytruda</td>
<td class="has-text-align-center" data-align="center">Merck &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>)</td>
<td class="has-text-align-center" data-align="center">$4.0B</td>
<td class="has-text-align-center" data-align="center">Cancer (various types)</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Eylea</td>
<td class="has-text-align-center" data-align="center">Regeneron Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) </td>
<td class="has-text-align-center" data-align="center">$3.4B</td>
<td class="has-text-align-center" data-align="center">Macular degeneration</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Prolia/Xgeva</td>
<td class="has-text-align-center" data-align="center">Amgen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>)</td>
<td class="has-text-align-center" data-align="center">$2.1B</td>
<td class="has-text-align-center" data-align="center">Osteoporosis, bone metastases</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Opdivo</td>
<td class="has-text-align-center" data-align="center">Bristol-Myers Squibb Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) </td>
<td class="has-text-align-center" data-align="center">$2.0B</td>
<td class="has-text-align-center" data-align="center">Cancer (various types)</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Darzalex</td>
<td class="has-text-align-center" data-align="center">Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>)</td>
<td class="has-text-align-center" data-align="center">$1.9B</td>
<td class="has-text-align-center" data-align="center">Multiple myeloma</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Avastin</td>
<td class="has-text-align-center" data-align="center">Roche Holdings AG (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RHHBY#OTC">RHHBY</a>)</td>
<td class="has-text-align-center" data-align="center">$1.8B</td>
<td class="has-text-align-center" data-align="center">Cancer (various types)</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">A breakdown of the top Medicare Part B drugs by spending in 2023, based on the latest data shared by the Centers for Medicare &amp; Medicaid Services (CMS).</figcaption></figure>
These are the stocks that are most likely to be hit by this announcement when markets open on Monday, given their sizable exposure to Medicare, especially being classified as Part B. 
According to a report by the Rand Corporation, a California-based policy think-tank, prescription drug prices in the U.S. are, on average, at least 2.78 times higher than other countries.
While Trump&#8217;s move is being criticized by the likes of crypto enthusiast Ed Krassenstein, calling it &#8220;just another Trump lie,&#8221; saying that an executive order can steer Medicare and Medicaid payments, but <a href="https://www.benzinga.com/general/health-care/25/05/45339399/trump-says-prescription-drug-prices-set-to-drop-by-30-to-80-almost-immediately-thanks-to-most-favored-nation-plan-mark-cuban-urges-president-to-force-tran">cannot force manufacturers</a> to cut prices. 
Others, such as billionaire investor Mark Cuban, have come out in support of the move, saying that it can &#8220;force transparency,&#8221; even if the President cannot force price cuts.
Drug pricing disparities have been a point of contention across the political spectrum. Recently, Novo Nordisk A/S&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) CEO, Lars Fruergaard Jorgensen, <a href="https://www.benzinga.com/general/biotech/24/09/40986953/novo-nordisk-ceo-to-face-senate-scrutiny-over-high-ozempic-and-wegovy-prices-hearing-scheduled-on">faced Senate scrutiny</a> on these vast differences, where he was targeted by Sen.&nbsp;Bernie Sanders&nbsp;(I-Vt.) for the high price of the company&#8217;s diabetes drug, Ozempic. 
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="135" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12033045/Screenshot-2025-05-12-at-1.00.28-PM-1024x135.png" alt="" class="wp-image-911404" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12033045/Screenshot-2025-05-12-at-1.00.28-PM-1024x135.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12033045/Screenshot-2025-05-12-at-1.00.28-PM-300x40.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12033045/Screenshot-2025-05-12-at-1.00.28-PM-768x101.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12033045/Screenshot-2025-05-12-at-1.00.28-PM-1536x202.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12033045/Screenshot-2025-05-12-at-1.00.28-PM.png 1594w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Novo Nordisk shares have an unfavorable price trend in the short, medium, and long term, but how does it compare with peers such as Johnson &amp; Johnson, Amgen, and Roche? Sign up for <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge</a> to find out.
Meanwhile, Novo Nordisk, Pfizer and J&amp;J were trading at least 3% lower in Monday premarket. 
Photo Courtesy: create jobs 51 On Shutterstock.com
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/05/45339784/mohamed-el-erian-warns-us-china-deal-reveals-americas-fear-of-empty-shelves-as-markets-rally-on-trade-optimism-peter-schiff-skeptical-without-renminbi-revaluation">Mohamed El-Erian Warns US-China Deal Reveals &#8216;America&#8217;s Fear Of Empty Shelves&#8217; As Markets Rally On Trade Optimism, Peter Schiff Skeptical Without Renminbi Revaluation</a></li>
</ul>

Health Care

AMGN

REGN

RHHBY

Trump's New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarket

The Federal Aviation Administration (FAA) is reportedly considering reducing the number of flights operating out of New Jersey's Newark Airport.
What Happened: The agency is set to meet with officials from several U.S. airlines to discuss scaling back flights out of Newark following disruptions caused by equipment malfunctions as well as staff shortages, CNBC reported <a href="https://www.cnbc.com/2025/05/11/newark-airport-flight-cuts-ahead-after-wee.html">on</a> Sunday.
"What you see in Newark is going to happen in other places across the country. It needs to be fixed," U.S. Transportation Secretary Sean Duffy said, according to the report.
Equipment outages caused air traffic controllers to lose communication as well as flight monitoring capabilities for over 90 seconds last month. There were also delays to over 1,000 flights due to equipment failures, the report suggests. The event also led to several staff members going on leave.
Questions have been raised over the aging air traffic infrastructure, which could reportedly cost over $31 billion to revamp, as well as more hiring of air traffic controllers, the report said.
"In ideal weather, with full staffing and with perfectly functioning technology, the FAA tells us that the airport (Newark) can only handle 77 flights per hour. And yet, the FAA regularly approves schedules of 80+ flights per hour almost every day between 3:00 pm and 8:00 p.m.," United Airlines Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) CEO Scott Kirby told employees in a note, according to the report.
Why It Matters: The news comes in as the U.S. aviation industry is dealing with a difficult quarter, as analysts have<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/45020724/airlines-face-significant-pressure-analysts-adjust-expectations-after-q1-results"> reset price targets </a>for several U.S. airlines following quarterly results.
American Airlines Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) recently announced it was <a href="https://www.benzinga.com/25/04/44982328/american-airlines-flies-into-uncertainty-q1-revenue-miss-2025-outlook-pulled-but-debt-plan-on-track?_gl=1&#x2A;1yry3sk&#x2A;_gcl_au&#x2A;NTM5OTQ2NTE5LjE3NDcwMjQyNzY.&#x2A;_ga&#x2A;R1MyLjEuczE3NDcwMzM3NzAkbzIkZzEkdDE3NDcwMzM3NzAkajAkbDAkaDA.&#x2A;_ga_V7ZK73W7N0&#x2A;czE3NDcwMzM1MzkkbzMkZzEkdDE3NDcwMzQyNzAkajAkbDAkaDA.">pulling its 2025 outlook </a>as the airline's operating revenue declined slightly to $12.55 billion, a 0.15% YoY decline.
Elsewhere, JetBlue Airways Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBLU#NASDAQ">JBLU</a>) is reportedly in talks with United Airlines over a <a href="https://www.benzinga.com/25/04/45093263/jetblue-in-talks-with-united-airlines-over-possible-partnership-report">possible partnership</a> between the two companies.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/04/45035715/airbus-finalizes-deal-with-spirit-to-take-over-assets-paving-way-for-boeing-acquisition">Airbus Finalizes Deal With Spirit To Take Over Assets, Paving Way For Boeing Acquisition</a></li>
</ul>
Photo: Synthetic Messiah/Shutterstock

Politics

Travel

JBLU

FAA Mulls Cutting Flights At Newark Airport Amid Staffing Woes And Equipment Failures: Report

Eli Lilly and Company&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) Zepbound demonstrated superior weight reduction compared to Novo Nordisk A/S&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) Wegovy in a 72-week head-to-head trial.
What Happened: Participants treated with tirzepatide (Zepbound) achieved an average weight loss of 20.2%, compared to 13.7% with semaglutide (Wegovy), representing a 47% greater relative weight reduction, according to detailed results from a direct comparison trial published in The New England Journal of Medicine. 
On average, those taking Zepbound lost 50.3 pounds, while those on Wegovy lost 33.1 pounds over the course of the study.
The SURMOUNT-5 Phase 3b open-label clinical trial met its primary endpoint and all five key secondary endpoints, with Zepbound showing superiority across all weight reduction targets. Nearly 65% of Zepbound users achieved at least 15% weight loss compared to 40% on Wegovy, and participants experienced greater waist circumference reduction —7.2 inches versus 5.1 inches.
The safety profile aligned with previous trials, with primarily gastrointestinal-related adverse events that were generally mild to moderate in severity. Discontinuation rates due to adverse events were 6.1% for Zepbound versus 8% for Wegovy.
See Also: <a href="https://www.benzinga.com/25/05/45340117/peter-lynch-said-the-suckers-going-up-is-no-buy-strategy-suggests-two-things-to-look-for-in-a-company-that-suggest-something-different">Peter Lynch Once Lamented People Are &#8216;Careful&#8217; When They Buy A Fridge But Will &#8216;Drop Thousands&#8217; On A Stock Tip They Heard On A Bus</a>
Why It Matters: Zepbound&#8217;s performance in this direct comparison strengthens Lilly&#8217;s position in the rapidly growing weight loss medication market. The drug operates as a dual GIP and GLP-1 receptor agonist, compared to Wegovy, which works solely as a GLP-1 receptor agonist.
The U.S. Food and Drug Administration recently expanded Zepbound&#8217;s approval to include <a href="https://www.benzinga.com/news/25/01/42933134/fda-approves-weight-loss-drug-zepbound-for-sleep-apnea-will-insurance-cover-this-1000-per-month-medication">treatment for moderate-to-severe obstructive sleep apnea</a> in adults with obesity. Clinical trials showed patients experienced an average of 25 fewer breathing interruptions per hour, with up to 50% no longer exhibiting OSA symptoms after one year.
WW International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WW#NASDAQ">WW</a>) recently announced a <a href="https://www.benzinga.com/news/25/04/45073094/weightwatchers-integrates-with-eli-lilly-to-expand-access-to-zepbound-stock-skyrockets-110">partnership with LillyDirect</a> pharmacy provider Gifthealth to simplify access to Zepbound for eligible self-pay clinic members. According to WeightWatchers, 33% of its clinic patients currently use Zepbound as part of their weight management plan, with prescriptions more than doubling in recent months.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45339966/bitcoin-creator-satoshi-nakamotos-estimated-wealth-crosses-bill-gates-amid-apex-cryptos-sharp-rebound">Bill Gates Left Behind By Satoshi Nakamoto: Bitcoin Creator&#8217;s Wealth Now Eclipses That Of Microsoft Co-Founder Amid Crypto&#8217;s Sharp Rebound</a></li>
</ul>
Image Via Shutterstock 
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Biotech

Eli Lilly's Zepbound Shows Superior Weight Loss Over Novo Nordisk's Wegovy In Head-To-Head Trial

monday.com Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) will release earnings results for the first quarter, before the opening <a href="https://www.benzinga.com/quote/mndy/earnings">bell on Monday, May 12.</a>
Analysts expect the Tel Aviv, Israel-based company to report quarterly earnings at 70 cents per share, up from 61 cents per share in the year-ago period. monday.com projects to report quarterly revenue at $275.96 million, compared to $216.91 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Feb. 10, Monday.com reported fiscal fourth-quarter revenue growth of 32% year-on-year to $267.98 million, beating the analyst consensus estimate of $261.37 million.
monday.com shares fell 1.2% to close at $278.24 on Friday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/MNDY/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Piper Sandler analyst Brent Bracelin maintained an Overweight rating and cut the price target from $385 to $305 on April 23, 2025. This analyst has an accuracy rate of 74%.</li>
<li>Jefferies analyst Brent Thill maintained a Buy rating and slashed the price target from $400 to $360 on March 31, 2025. This analyst has an accuracy rate of 76%.</li>
<li>Tigress Financial analyst Ivan Feinseth maintained a Buy rating and raised the price target from $340 to $450 on Feb. 21, 2025. This analyst has an accuracy rate of 72%.</li>
<li>Goldman Sachs analyst Kash Rangan maintained a Buy rating and boosted the price target from $350 to $400 on Feb. 11, 2025. This analyst has an accuracy rate of 66%.</li>
<li>Keybanc analyst Jackson Ader upgraded the stock from Sector Weight to Overweight with a price target of $420 on Feb. 11, 2025. This analyst has an accuracy rate of 68%.</li>
</ul>
Considering buying MNDY stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="571" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12035951/image-114-1024x571.png" alt="" class="wp-image-911439" style="width:547px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12035951/image-114-1024x571.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12035951/image-114-300x167.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12035951/image-114-768x428.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12035951/image-114.png 1108w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45315727/top-3-industrials-stocks-that-may-collapse-in-may">Top 3 Industrials Stocks That May Collapse In May</a> </li>
</ul>
Photo via Shutterstock

Price Target

Monday.Com Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

President Donald Trump&#8216;s proposed millionaire tax, which aims to increase the tax rate on income over $2.5 million, is being seen as largely symbolic and unlikely to significantly impact revenue or inequality by experts.
What Happened: Howard Gleckman, from the Urban-Brookings Tax Policy Center, stated that the proposed tax change would not significantly affect revenue or inequality, <a href="https://fortune.com/2025/05/11/trump-millionaire-tax-inequality-billionaires/">reported</a> Fortune. The tax hike, which would increase the rate from 37% to 39.6% on income over $2.5 million, is expected to raise about $8.2 billion this year and impact around 80,000 households.
Most&nbsp;millionaires and billionaires in the&nbsp;U.S. earn a small portion&nbsp;of their income in the&nbsp;form of salaries, with the majority coming from capital gains, which are taxed at a lower rate. Program director at&nbsp;the Institute for Policy Studies,&nbsp;Sarah Anderson, told the publication that the proposed tax increase would have minimal impact on billionaires as&nbsp;they take very little compensation&nbsp;from their companies.
"It's not going to change the revenue very much and it's going to give a lot of Republicans heartburn," stated Garrett Watson from the Tax Foundation.
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/25/05/45337485/this-is-bad-like-actually-bad-a-man-describes-the-crisis-at-a-big-fulfillment-warehouse-tariffs-are-hitting-" target="_blank" rel="noreferrer noopener">&#8216;This Is Bad. Like Actually Bad&#8217;—A Man Describes The Crisis At A Big Fulfillment Warehouse: Tariffs Are Hitting Way Harder Than We Thought</a>
Why It Matters: The Republican Party, long opposed to tax hikes, is now considering them to help cover $4.5 trillion in costs from extending the 2017 tax cuts and advancing Trump's priorities like exempting Social Security income and tips from taxes.
Trump&#8217;s tax proposal comes amid a political storm within the Republican Party. Trump&#8217;s support for a tax increase on millionaires <a href="https://www.benzinga.com/25/04/45037541/trumps-proposed-millionaires-tax-ignites-political-firestorm-within-republicans-doing-so-would-be-political-death-caution-experts">sparked controversy </a>and debate among Republicans and conservatives. Opposition to tax hikes is strong among traditional Republicans, including Trump advisors Steve Moore and Larry Kudlow and GOP Sen. Dave McCormick (R-Pa.) and Ted Cruz (R-Texas). However, Sen. Mike Crapo (R-Idaho) expressed potential openness to being persuaded.
Earlier in May, Trump&#8217;s ambitious budget package, dubbed the &#8220;Big, Beautiful Bill,&#8221; was facing a <a href="https://www.benzinga.com/markets/equities/25/05/45217098/trumps-big-beautiful-bill-takes-shape-gop-pushes-tax-cuts-border-wall-funding-and-deep-spending-reductions-ahead-of-memorial-day-deadline">bumpy road </a>in Congress as Republican lawmakers worked to balance tax cuts with spending priorities.
Just days later, Trump revived the push for a <a href="https://www.benzinga.com/news/25/05/45317302/trump-renews-effort-to-hike-taxes-on-wealthy-americans-holds-talks-with-mike-johnson-report">tax increase </a>on the wealthiest Americans as part of his forthcoming tax package. The White House believes that this tax increase on the wealthiest will facilitate substantial tax cuts for the middle and working class and safeguard Medicaid.
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/25/05/45339953/apple-exec-says-iphone-users-are-ditching-google-search-now-chamath-palihaptiya-urges-the-tech-giant-to-stop-wait" target="_blank" rel="noreferrer noopener">Apple Executive Says iPhone Users Are Ditching Google — Now Chamath Palihaptiya Urges The Search Giant To Stop Waiting For Data And Start Fighting Models Like ChatGPT</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Trump's Millionaire Tax More Of A Symbolic Gesture Than Step Towards Reducing Inequality, Warn Experts: 'It's Going To Give A Lot Of Republicans Heartburn'

Diversified Energy Q1 Revenue $346.9M Up From $193.62M YoY, Adj. EBITDA $138.64M Up From $102.08M YoY

Alibaba Group Holding&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) Chairman, Joe Tsai, has announced that the tech giant plans to integrate artificial intelligence (AI) into its operations within the next three to five years.
What Happened: Tsai unveiled Alibaba Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>)&#8217;s future AI-driven strategy at AliDay, the company&#8217;s annual event for employees and their families. Tsai stated, &#8220;In the next three to five years, all of our businesses should be driven by AI,&#8221; <a href="https://www.scmp.com/tech/big-tech/article/3309905/ai-will-be-mainstay-alibabas-business-next-3-5-years-chairman-joe-tsai-says">reported</a> the South China Morning Post. Founder Jack Ma was also in attendance at the annual event.
Tsai views AI as a crucial tool to expand Alibaba&#8217;s user base across its e-commerce and other business sectors. During the two-day event, Tsai and Chief People Officer Jane Jiang Fang addressed several questions from the staff, including&nbsp;the impact of the U.S.-China&nbsp;trade war on the company and the country.
 Tsai expressed confidence in China&#8217;s position in the trade war, stating, &#8220;We&nbsp;have the upper hand in&nbsp;the trade war.&#8221; The Chairman explained that a significant portion of China&#8217;s exports to the U.S. includes high-tech products with intricate supply chains, unlike American exports like oil and soybeans, which are easier to replace.
SEE ALSO:&nbsp;<a href="https://benzinga.com/markets/cryptocurrency/25/05/45192498/bitcoins-key-level-is-96500-analyst-warns-but-heres-what-could-trigger-a-breakdown" target="_blank" rel="noreferrer noopener">Bitcoin&#8217;s Key Level Is $96,500, Analyst Warns, But Here&#8217;s What Could Trigger A Breakdown &#8211; Benzinga</a>
Why It Matters: This announcement comes after Alibaba&#8217;s recent launch of Qwen 3, its most advanced artificial intelligence model to date. The system features <a href="https://www.benzinga.com/25/04/45057716/alibabas-qwen-3-launch-takes-aim-at-deepseeks-disruption-and-baidus-ernie-turbo-models">hybrid reasoning </a>capabilities, blending traditional AI tasks with enhanced problem-solving skills. This move towards AI integration aligns with Alibaba&#8217;s ongoing efforts to stay at the forefront of technological innovation.
In February, the company announced a record capital expenditure of 380 billion yuan ($52.4 billion) over three years to boost computing resources and AI infrastructure.
Notably, the Chinese tech giant has begun allowing employees from its six major business groups to communicate through an internal website, aiming to foster synergies across its operations following a major restructuring two years ago.
Price Action:&nbsp;Alibaba ADRs slid 0.37% to close at $125.33 on Friday. On a year-to-date basis, the ADRs climbed 47.53%, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
According to Benzinga Edge Stock Rankings, Alibaba has a growth score of 73.51% and a momentum rating of 93.82.&nbsp;<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound" target="_blank" rel="noreferrer noopener">Click here to see how it compares to other leading</a>&nbsp;tech companies.
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/news/25/05/45337285/marjorie-taylor-greene-frustrated-and-upset-with-team-trump-attempted-assassination-of-scott-bessent-jd-vanc" target="_blank" rel="noreferrer noopener">Marjorie Taylor Greene &#8216;Frustrated And Upset&#8217; With Team Trump, Attempted Assassination Of Scott Bessent, JD Vance Slams Jerome Powell And More: Top Political Updates</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

BABA

Alibaba Asserts Chinese Tech Dominance, Vows Major AI Focus In Next 3-5 Years: 'We Have The Upper Hand In The Trade War'

BALL

Ball Corporation Launches €750M Senior Notes Offering Due 2032 For Corporate Financing And Strategic Flexibility

Future Fund LLC's Gary Black believes Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) as well as Uber Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) will benefit from increased EV adoption as well as growth in Autonomous Driving.
What Happened: In a post on the social media platform X, the investor shared his thoughts on why he invested in both companies on Sunday. "We own both $UBER and $TSLA for different reasons,"
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We own both <a href="https://twitter.com/search?q=%24UBER&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$UBER</a> and <a href="https://twitter.com/search?q=%24TSLA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$TSLA</a> for different reasons. Our investment thesis on <a href="https://twitter.com/search?q=%24UBER&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$UBER</a> is that as autonomy becomes table stakes for remaining in the automobile business, many auto manufacturers will achieve and be granted deployment licenses for unsupervised autonomy. <a href="https://twitter.com/search?q=%24UBER&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$UBER</a> with…
&mdash; Gary Black (@garyblack00) <a href="https://twitter.com/garyblack00/status/1921351661903020335?ref_src=twsrc%5Etfw">May 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Black said that as autonomous driving gathers steam, more companies would adopt the technology and be granted licenses to operate unsupervised robotaxis in the future. "$UBER with 170M MAUs will by 2026 year-end offer a driverless option that reduces the cost per mile from $2/mile to $1/mile," he said in the post.
"We see $UBER Non-GAAP EPS increasing from $3/share in 2025 to $8/share by 2030.&nbsp; Our UBER PT is $120." Black said.
He then talked about Tesla and how Elon Musk's EV giant could stand to gain from increased EV adoption throughout the globe. "We own $TSLA because as global EV adoption increases from its current 20% to 50% by 2030, TSLA deliveries should increase from 1.7M in 2025 to 5.0M by 2030," he shared.
Black also shared how autonomous driving could help boost sales before setting a $310 price target on Tesla stock. "We expect unsupervised autonomy to sell more Teslas and increase the FSD take rate from its current 15% to 33%." the investor said.
Why It Matters: The investor has been an advocate for autonomous vehicles. He had recently <a href="https://www.benzinga.com/25/05/45339797/gary-black-doubles-down-on-ubers-autonomy-upside-reflects-on-tesla-debates-i-was-right-on-volume-pr-and-robotaxis">doubled down </a>on Uber's growth as autonomous vehicles are steadily gaining pace in the U.S.
Black has also previously shared that Musk's company <a href="https://www.benzinga.com/news/25/05/45336172/tesla-bull-gary-black-reaffirms-elon-musks-company-best-positioned-to-capitalize-on-evs-and-autonomo">is "best positioned"</a> to&nbsp;
Capitalize on EV growth in the country. "As EV adoption and demand for autonomy increases, $TSLA remains the best positioned to capitalize on these two megatrends," he said.
Elsewhere, <a href="https://www.benzinga.com/25/05/45309828/gary-black-says-lyft-is-worthy-of-increased-investment-following-q1-earnings-call">the investor also hailed </a>Uber rival Lyft Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) as the ride-hailing service surprised analysts by beating expectations. The company revealed that it attained a $.01 EPS vs a projected -$.02 loss, at the Q1 earnings call last Thursday.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="191" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12020454/UBER-MAY-12-2025-1024x191.jpg" alt="" class="wp-image-911303" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12020454/UBER-MAY-12-2025-1024x191.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12020454/UBER-MAY-12-2025-300x56.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12020454/UBER-MAY-12-2025-768x143.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12020454/UBER-MAY-12-2025-1536x287.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12020454/UBER-MAY-12-2025.jpg 1651w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
UBER scores well on Momentum and Growth metrics and has a satisfactory score on the value metric. For more such insights, sign up for<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"> Benzinga Edge</a> today!
Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45283323/gary-black-thinks-uber-could-have-an-advantage-over-elon-musk-and-tesla-in-the-robotaxi-race">Uber Could Outpace Elon Musk&#8217;s Tesla In Robotaxi Race, Says TSLA Bull Gary Black</a></li>
</ul>
Photo courtesy: DenPhotos / Shutterstock.com

Top Bull Gary Black Shares Why He Is Holding On To UBER And TSLA: 'Our investment Thesis On…'

<ul>
<li>Nokia to deploy its high-performance, energy-efficient Habrok Massive MIMO radios and Levante baseband solutions to boost the coverage and capacity of Optus's 5G network.&nbsp;</li>
<li>Partnership advances Optus's goal of providing faster speeds and improving service quality for regional communities and businesses.</li>
</ul>

Nokia Deploys Habrok And Levante Technology To Expand Optus 5G Reach Across Regional Australia With Improved Speed And Sustainability

<ul>
<li>Creates ~$1.5 billion revenue company in fast-growing collagen-based health, nutrition and food sectors</li>
<li>85% owned and consolidated by Darling Ingredients</li>
<li>Non-cash transaction, combining assets, capabilities</li>
<li>Strengthens foundation around serving food and pharma customers</li>
<li>Provides a platform for accelerated product development and growth</li>
<li>Creates an opportunity to unlock significant shareholder value</li>
</ul>

Darling Ingredients (85%) And Tessenderlo Group (15%) To Merge Collagen Units Into $1.5B Global Venture Nextida

<ul>
<li>ABCL575 is a novel, half-life extended anti-OX40L monoclonal antibody that is being developed for the treatment of moderate-to-severe atopic dermatitis (AD)</li>
<li>In preclinical studies, ABCL575 shows potent inhibition of inflammatory pathways, favorable in vivo pharmacokinetics (PK), and potential for less frequent dosing compared to a clinical benchmark</li>
</ul>

ABCL

Reported Friday, AbCellera's ABCL575 Matches Clinical Benchmark And Demonstrates Extended Half-Life In Preclinical AD Studies

With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
<ul class="wp-block-list">
<li>Wall Street expects Fox Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOX#NASDAQ">FOX</a>) to report quarterly earnings at 91 cents per share on revenue of $4.18 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Fox shares gained 1% to $47.20 in after-hours trading.</li>
<li>Hawaiian Electric Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HE#NYSE">HE</a>) reported first-quarter earnings of 23 cents per share, in-line with market estimates. The company reported $744.07 million in sales during the quarter. Hawaiian Electric shares rose 0.1% to $10.50 in the after-hours trading session.</li>
<li>Analysts are expecting NRG Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>) to post quarterly earnings at $1.49 per share on revenue of $7.83 billion. The company will release earnings before the markets open. NRG Energy shares gained 1.4% to $121.03 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul class="wp-block-list">
<li>After the closing bell, DaVita Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>) is projected to post quarterly earnings at $1.95 per share on revenue of $3.21 billion. DaVita shares fell 0.4% to $143.15 in the after-hours trading session.</li>
<li>Analysts expect Southwest Gas Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWX#NYSE">SWX</a>) to report quarterly earnings at $1.50 per share on revenue of $1.50 billion. Southwest Gas shares fell 1.3% to $74.67 in after-hours trading.</li>
</ul>
Check This Out: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45315727/top-3-industrials-stocks-that-may-collapse-in-may">Top 3 Industrials Stocks That May Collapse In May</a> </li>
</ul>
Photo via Shutterstock

Fox, NRG Energy And 3 Stocks To Watch Heading Into Monday

LGIH

Reported Friday, LGI Homes Launches Northridge Community Near Buffalo, Minnesota, Expanding Affordable Housing Options In Montrose

DSVSF

Reported Friday, Newmont Reduces Stake In Discovery Silver With Sale Of 50.5M Shares Worth  C$124M, Drops Below 10% Ownership Threshold

Press Releases

Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024

Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1

Fulgent to Participate in Upcoming Conferences

Fulgent Reports Third Quarter 2024 Financial Results

Foundation Medicine to Launch Hereditary Germline Tests, FoundationOne®Germline and FoundationOne®Germline More, in the United States Through a Partnership with Fulgent Genetics

Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025

Fulgent Reports Fourth Quarter and Full Year 2024 Financial Results

Mutual Funds

DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

Comments

Fulgent Genetics

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO